U Martinowitz Selected Research

U Martinowitz Research Topics

25	Hemophilia A (Haemophilia) 01/2014 - 03/2000
19	Hemorrhage 12/2015 - 01/2000
6	Wounds and Injuries (Trauma) 12/2015 - 04/2000
3	Hemophilia B (Haemophilia B) 11/2015 - 07/2008
3	Hepatitis C 03/2008 - 07/2006
2	Thrombocytopenia (Thrombopenia) 08/2015 - 05/2007
2	Fibrosis (Cirrhosis) 11/2007 - 07/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2007 - 07/2006
2	Liver Diseases (Liver Disease) 07/2006 - 01/2006
2	Infections 01/2006 - 03/2000
2	Hypothermia 04/2005 - 04/2001
1	Hematoma 12/2015
1	Hypotension (Low Blood Pressure) 12/2015
1	Factor XI Deficiency (Hemophilia C) 09/2009
1	Contusions 07/2008
1	Craniocerebral Trauma (Head Injury) 07/2008
1	Brain Contusion 07/2008
1	Penetrating Head Injuries (Penetrating Head Injury) 07/2008
1	Chronic Hepatitis C 01/2006
1	Virus Diseases (Viral Diseases) 01/2006
1	Acidosis 04/2005
1	Placenta Previa 10/2003
1	Pre-Eclampsia (Preeclampsia) 10/2003
1	Rupture 10/2003
1	Pain (Aches) 03/2003
1	Thrombophlebitis 05/2002
1	von Willebrand Diseases (von Willebrand's Disease) 05/2002
1	Disseminated Intravascular Coagulation 09/2001
1	Protein S Deficiency (Deficiency, Protein S) 06/2000
1	Ischemic Stroke 06/2000
1	Antithrombin III Deficiency 06/2000
1	Hepatitis 03/2000
1	Patellar Dislocation 03/2000
1	Osteoarthritis 03/2000

13	recombinant FVIIa (rFVIIa)FDA Link 09/2013 - 04/2000
8	Factor VIIa (Activated Factor VII)IBA 12/2015 - 04/2000
7	Factor VIII (Coagulation Factor VIII)IBA 09/2013 - 01/2000
4	Hemostatics (Antihemorrhagics)IBA 12/2015 - 09/2001
4	Blood Coagulation Factors (Coagulation Factor)IBA 12/2015 - 04/2001
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2015 - 05/2002
3	anti-inhibitor coagulant complexIBA 08/2015 - 07/2008
3	Thrombin FDA Link 09/2013 - 01/2006
2	Fibrinogen (Factor I)FDA Link 08/2015 - 05/2007
2	Prothrombin (Factor II)IBA 08/2015 - 06/2000
2	sugar formulated recombinant FVIIIIBA 01/2014 - 05/2009
2	Biomarkers (Surrogate Marker)IBA 11/2007 - 07/2006
2	RNA (Ribonucleic Acid)IBA 07/2006 - 01/2006
2	Hepatitis C AntibodiesIBA 07/2006 - 01/2006
2	YttriumIBA 09/2004 - 07/2001
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	AlbuminsIBA 11/2015
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 08/2015
1	AntigensIBA 01/2014
1	recombinant factor VIII N8IBA 09/2013
1	IB1001IBA 11/2012
1	FHDIBA 11/2011
1	Sucrose (Saccharose)IBA 05/2009
1	Liposomes (Liposome)IBA 09/2008
1	Ribavirin (Virazole)FDA LinkGeneric 03/2008
1	InterferonsIBA 03/2008
1	Hyaluronic Acid (Hyaluronan)IBA 07/2006
1	EnzymesIBA 01/2006
1	AnticoagulantsIBA 12/2001
1	GelatinIBA 12/2001
1	Oxidoreductases (Dehydrogenase)IBA 06/2000
1	Antiphospholipid AntibodiesIBA 06/2000
1	Protein SIBA 06/2000
1	factor V LeidenIBA 06/2000
1	AntithrombinsIBA 06/2000
1	Protein CIBA 06/2000
1	5,10-methylenetetrahydrofolic acidIBA 06/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2000

7	Therapeutics 09/2013 - 12/2001
3	Injections 11/2015 - 09/2000
2	Operative Surgical Procedures 09/2009 - 09/2000
1	Resuscitation 12/2015
1	Surgical Hemostasis 12/2015
1	Intravenous Infusions 12/2015
1	Off-Label Use 04/2005
1	Duration of Therapy 03/2003
1	Sutures (Suture) 12/2001
1	Contraindications 09/2001
1	Hemostatic Techniques 09/2001
1	Intravenous Administration 04/2001
1	Highly Active Antiretroviral Therapy (HAART) 05/2000
1	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2000
1	Arthrodesis 03/2000